EUROFINS SCIENT Gross Profit 2018-2024 | ERFSF
EUROFINS SCIENT annual/quarterly gross profit history and growth rate from 2018 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- EUROFINS SCIENT gross profit for the quarter ending June 30, 2024 was $M, a NAN% increase year-over-year.
- EUROFINS SCIENT gross profit for the twelve months ending June 30, 2024 was $0M, a NAN% increase year-over-year.
- EUROFINS SCIENT annual gross profit for 2023 was $1.336B, a 10.39% decline from 2022.
- EUROFINS SCIENT annual gross profit for 2022 was $1.491B, a 31.51% decline from 2021.
- EUROFINS SCIENT annual gross profit for 2021 was $2.177B, a 41.07% increase from 2020.
| EUROFINS SCIENT Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2023 | $1,336 |
| 2022 | $1,491 |
| 2021 | $2,177 |
| 2020 | $1,543 |
| 2019 | $933 |
| 2018 | $769 |
| 2017 | $580 |
| 2016 | $2,762 |
| 2015 | $ |
| EUROFINS SCIENT Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2024-06-30 | |
| 2023-06-30 | |
| 2022-12-31 | |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| 2020-06-30 | |
| 2019-12-31 | |
| 2019-06-30 | |
| 2018-12-31 | |
| 2018-06-30 | |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.228B | $7.522B |
| Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $149.005B | 27.54 |
| Elevance Health (ELV) | United States | $90.276B | 11.81 |
| CVS Health (CVS) | United States | $82.998B | 12.15 |
| Cencora (COR) | United States | $47.050B | 17.08 |
| DiDi Global (DIDIY) | China | $24.788B | 0.00 |
| Natera (NTRA) | United States | $22.891B | 0.00 |
| ICON (ICLR) | Ireland | $15.361B | 13.68 |
| Doximity (DOCS) | United States | $14.388B | 74.82 |
| BioMerieux (BMXMF) | France | $13.819B | 0.00 |
| Revvity (RVTY) | United States | $13.662B | 22.91 |
| Viatris (VTRS) | United States | $12.891B | 3.97 |
| Solventum (SOLV) | United States | $12.825B | 0.00 |
| Avantor (AVTR) | United States | $12.168B | 17.87 |
| CochLear (CHEOY) | Australia | $11.076B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.364B | 26.93 |
| HealthEquity (HQY) | United States | $9.766B | 49.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.787B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.772B | 15.02 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.784B | 26.90 |
| Organon (OGN) | United States | $3.935B | 4.01 |
| BrightSpring Health Services (BTSG) | United States | $3.839B | 81.67 |
| Sotera Health (SHC) | United States | $3.818B | 20.42 |
| Surgery Partners (SGRY) | United States | $3.288B | 37.49 |
| Concentras Parent (CON) | United States | $2.893B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.622B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.467B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.108B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.097B | 0.00 |
| PACS (PACS) | United States | $2.041B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.921B | 50.40 |
| Progyny (PGNY) | United States | $1.904B | 38.55 |
| Premier (PINC) | United States | $1.623B | 10.39 |
| Agilon Health (AGL) | United States | $1.409B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| CareDx (CDNA) | United States | $1.314B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.207B | 11.81 |
| Establishment Labs Holdings (ESTA) | $1.010B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.892B | 6.04 |
| Embecta (EMBC) | United States | $0.863B | 5.92 |
| Auna S.A (AUNA) | Luxembourg | $0.639B | 0.00 |
| DocGo (DCGO) | United States | $0.565B | 21.31 |
| SBC Medicals (SBC) | United States | $0.492B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.486B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.458B | 0.00 |
| MultiPlan (MPLN) | United States | $0.446B | 0.00 |
| Enhabit (EHAB) | United States | $0.437B | 37.83 |
| QDM (QDMI) | Hong Kong, SAR China | $0.421B | 11.03 |
| Nutex Health (NUTX) | United States | $0.359B | 0.00 |
| LifeMD (LFMD) | United States | $0.332B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.313B | 0.00 |
| Beauty Health (SKIN) | United States | $0.207B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.181B | 0.00 |
| Biodesix (BDSX) | United States | $0.143B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.136B | 0.00 |
| So-Young (SY) | China | $0.112B | 19.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.090B | 0.00 |
| ModivCare (MODV) | United States | $0.084B | 4.57 |
| IceCure Medical (ICCM) | Israel | $0.075B | 0.00 |
| Oncology Institute (TOI) | United States | $0.073B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| Singular Genomics Systems (OMIC) | United States | $0.051B | 0.00 |
| OncoCyte (OCX) | United States | $0.045B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.022B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.017B | 0.00 |
| KindlyMD (KDLY) | United States | $0.017B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |